AtriCure recently closed its LeAAPS clinical trial, the largest randomized cardiac surgery clinical trial to date, with 6,500 patients participating to help prevent strokes and/or embolisms – setting a benchmark in the industry. The City of Mason has partnered with AtriCure for more than a decade, supporting its advancement of cardiac care and innovation in the Mason Biohub.
Read more about AtriCure’s groundbreaking study.
Read moreAfter a decade at their North American Regional Service Center in Mason, Festo, a global manufacturing and automation leader, celebrates 100 years of innovation worldwide. With a nearly 4,000 solar panel installation covering more than 85,000 square-feet, plus a $90 million expansion planned, Festo continues to progress toward the future of industry 4.0.
See all the details about Festo’s anniversary milestone.
Read moreThe Lindner Center of Hope’s groundbreaking marks the start of their largest expansion since opening two decades ago in Mason. This expansion further broadens their nation-leading mental health evidence-based medicine and treatment, and genetic research capabilities.
Read more about the expansion in the Cincinnati Business Courier.
Read moreMira Precision Health announces a new partnership with Oxford Cancer Biomarkers on its ToxNav® oncological testing initiative. This partnership connects our community to novel health technology in the Mason Living Lab and adds to our BioHub’s dynamic portfolio of medical innovation.
Read more about the partnership announcement.
Read moreBolstered by their 2024 merger with Hydro Systems, RH Aero Systems now serves 85% of the global engine market. Plus, with an impressive 3-year, 256% revenue growth, they are ranked the fifth fastest growing company in the region.
Read more about RH Aero’s growth in the Cincinnati Business Courier.
Read moreMyriad Genetics’ GeneSight® DNA test results analyzed in their Mason-based headquarters and laboratories have improved mental health care and treatment for more than 3 million patients nationwide.
Read a GeneSight patient’s testimonial on WCPO.
Read moreAtriCure’s announcement of their new surgical tool, the EPi-Ease™ Epicardial Access Device, is yet another breakthrough innovation that will benefit physicians and patients around the globe.
Learn more about AtriCure’s latest innovation here.
Read moreMason-based Lindner Center of Hope has begun a new clinical trial on bipolar disorder treatment and interventions. Lindner Center Chief Research Officer Dr. Susan McElroy and Associate Chief Research Officer Dr. Franciso Romo-Nava, Ph.D., will serve as co-leads in partnership with University of Cincinnati researchers.
Read more about the clinical trial here.
Read moreAtriCure, a global biohealth leader and a Mason partner for a decade, was named one of REDI Cincinnati’s 2025 James A. Wuenker Growth Award winners for their dedication to innovation and growth in the region.
Read moreThe U.S. Bureau of Labor Statistics named Warren County fifth in the nation for fastest-growing average wages established by major biohealth, technology, and manufacturing company investments in Mason, plus strategic partnerships with economic development leaders REDI Cincinnati and JobsOhio.
Check out details in Dayton Daily News.
